UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060020
Receipt number R000068646
Scientific Title Reproducibility and clinical validity of liver stiffness measurement using EUS-guided shear-wave elastography in patients with steatotic liver disease: an analysis using Baveno VII stratification
Date of disclosure of the study information 2025/12/09
Last modified on 2025/12/09 06:22:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Reproducibility of liver stiffness measurement using EUS-SWE and its association with a simple platelet count and AST/ALT ratio-based risk stratification in steatotic liver disease: a prospective observational study

Acronym

HITO-EUS-SWE

Scientific Title

Reproducibility and clinical validity of liver stiffness measurement using EUS-guided shear-wave elastography in patients with steatotic liver disease: an analysis using Baveno VII stratification

Scientific Title:Acronym

HITO-EUS-SWE-SLD

Region

Japan


Condition

Condition

steatotic liver disease (SLD)

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the reproducibility (primary) and clinical validity (secondary) of liver stiffness (kPa) measured by EUS-SWE in patients with steatotic liver disease (SLD), including MASLD/MetALD/ALD. Clinical validity will be assessed by its association with a Baveno VII-referenced alternative stratification based on platelet count (PLT) and the AST/ALT ratio (AAR) (PLT-AAR).

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

intra-operator reproducibility assessed using ICC and Bland-Altman analysis (mean difference and 95% limits of agreement)

Key secondary outcomes

Clinical validity assessed by AUROC for PLT-AAR stratification with sensitivity, specificity, and optimal thresholds; correlations with PLT, AAR, FIB-4; and feasibility/quality metrics including IQR/median, success rate, procedure time, and complications.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Inclusion criteria: (1) Adults aged 20 years and older clinically diagnosed with SLD (MASLD/MetALD/ALD) scheduled to undergo EUS as part of routine care; (2) ability to provide written informed consent.

Key exclusion criteria

Exclusion criteria: conditions judged unsuitable for EUS (e.g., severe general condition, high bleeding risk), pregnancy or suspected pregnancy, comorbidities or cognitive impairment interfering with participation, or any other reason deemed inappropriate by the principal investigator.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Takako
Middle name
Last name Nomura

Organization

HITO Medical Center

Division name

Department of Gastroenterology and Hepatology

Zip code

7990121

Address

788-1, Kamibun-Cho, Shikokutyuou-city, Ehime, Japan

TEL

0896582222

Email

nomura.takako@hito-medical.net


Public contact

Name of contact person

1st name Takako
Middle name
Last name Nomura

Organization

HITO Medical Center

Division name

Department of Gastroenterology and Hepatology

Zip code

7990121

Address

788-1, Kamibun-Cho, Shikokutyuou-city, Ehime, Japan

TEL

0896582222

Homepage URL


Email

nomura.takako@hito-medical.net


Sponsor or person

Institute

HITO Medical Center

Institute

Department

Personal name



Funding Source

Organization

HITO Medical Center

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

HITO Medical Center

Address

788-1, Kamibun-Cho, Shikokutyuou-city, Ehime, Japan

Tel

0896582222

Email

nomura.takako@hito-medical.net


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 12 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 12 Month 01 Day

Date of IRB


Anticipated trial start date

2025 Year 12 Month 09 Day

Last follow-up date

2029 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This is a prospective non-interventional observational study in which EUS-SWE liver stiffness measurements will be additionally obtained within clinically indicated EUS and analyzed. No new treatment or drug administration is involved. The main study-related burden is an approximately 3-minute extension of the examination time. Data will be managed using linkable anonymization. The study is funded by departmental research funds without industry funding or device provision. The study outline will be registered and publicly available in UMIN-CTR.


Management information

Registered date

2025 Year 12 Month 09 Day

Last modified on

2025 Year 12 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068646